Viral safety step 1: low-pH inactivation

📍 Where we are: Part 14 of the journey — right after the capture step, we now make the antibody stream safe from viruses.

Our monoclonal antibody (mAb) — a Y-shaped protein drug grown by living cells — is mostly pure now. But because it was made by living mammalian cells (CHO cells, from Chinese hamster ovary), there is a tiny theoretical risk that a virus could be hiding in the liquid. So we add a deliberate step to destroy any virus that might be there. This is the first of two viral-safety steps.

The simple version

Think about milk. Fresh milk can carry germs, so we pasteurize it: we hold it at a controlled condition (heat) for a set amount of time, long enough to kill anything harmful, then move on. Low-pH viral inactivation is the same idea — but instead of heat, we use a gentle acid bath, held for a set time, to break apart any virus while leaving our antibody unharmed.

What actually happens

First, a quick word on pH. pH is just a number that tells you how acidic or basic a liquid is. Low pH means acidic (like lemon juice or vinegar); high pH means basic (like soap). Most viruses, and especially the fragile ones, hate a strongly acidic environment.

Here is the lucky part. The Protein A capture step you just read about releases the antibody in an already-acidic liquid (the eluate — the liquid that comes off the column). So the stream arrives almost ready for this step.

The sequence is simple:

1. Adjust the pH down. A small amount of acid is added to bring the liquid to a precise low pH (often around pH 3.5).
2. Hold it there. The acidic stream is held for a set time — typically 30 to 60 minutes. This is called the hold time, and it must be long enough, proven in advance.
3. Destroy the envelope. Many dangerous viruses wear an outer fatty coat called an envelope. The acid rips this coat apart. Without its envelope, the virus can no longer infect anything. It is broken.
4. Neutralize. A base is added to bring the pH back up to a safe, gentle level. Our antibody, which tolerates the brief acid bath, is now both pure and safer.

Why it matters

This step does not just clean the product — it protects the patient. A biologic medicine is often injected straight into the body, so it must carry no live virus at all.

Regulators (the government safety agencies that approve medicines) require something called a viral clearance strategy: documented proof that the process can remove or destroy viruses. And they insist it be orthogonal. Orthogonal means using two completely different methods that work in different ways, so each catches what the other might miss.

Low-pH inactivation is the chemical method, and it is excellent at killing enveloped viruses. Later, a viral filter provides the physical method, straining out viruses by size — including ones with no envelope that acid cannot touch. Two different traps, two different weaknesses covered.

This step is non-negotiable

Viral safety is not a place to cut corners. The hold time and pH are proven ahead of time in special validation studies, then watched closely on every batch. If the pH is wrong, or the hold is too short, the step may fail silently — the liquid looks identical, but a virus could survive. That is why these numbers are treated as critical and recorded for every single batch.

In the real world

In the standard commercial process, low-pH inactivation is done in a tank: fill it, hold for the set time, neutralize, move on. Simple and reliable.

The modern, continuous approach — pioneered by the U.S. NIIMBL institute and its SABRE pilot facility — never stops the flow. Instead of a tank, the acidic stream travels through a long coil or chamber sized so that every drop spends exactly the right hold time inside before coming out the other end. This is called Continuous Viral Inactivation (CVI). It fits a step that was once a pause into a smooth, always-moving production line.

Key terms

• pH — a number describing how acidic (low) or basic (high) a liquid is.
• Eluate — the liquid carrying the antibody after it is washed off a chromatography column.
• Hold time — the set, proven length of time the stream stays at low pH (often 30 to 60 minutes).
• Envelope — the outer fatty coat on some viruses; acid destroys it.
• Viral clearance — the documented strategy proving the process removes or destroys viruses.
• Orthogonal — using two different methods so each catches what the other might miss.
• Continuous Viral Inactivation (CVI) — doing this step in a flowing coil instead of a tank, as NIIMBL/SABRE do.